Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07623031 · ClinicalTrials.gov registry record · NA
Dual-Language B-MORE for Hypertension
A NA study, sponsored by Florida State University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07623031 is a NA study that has not yet begun recruiting, run by Florida State University. The registered enrollment target is 20 participants.
The verdict
NCT07623031, a NA study, has not yet begun recruiting, sponsored by Florida State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot study is a single-arm clinical feasibility trial evaluating the feasibility, acceptability, and preliminary efficacy of a brief adaptation of Mindfulness-Oriented Recovery Enhancement (B-MORE) for reducing stress and high blood pressure in hypertensive English- and Spanish-speaking patients (n=20). The intervention, a 2-hour online training in stress management and hypertension, will be delivered virtually in a small-group format over two 60-minute sessions.
Interventions
- BEHAVIORAL Behavioral: B-MORE (Brief Mindfulness-Oriented Recovery Enhancement)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07623031
The ClinicalTrials.gov registry entry for NCT07623031 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavioral: B-MORE (Brief Mindfulness-Oriented Recovery Enhancement) is the first listed.
NCT07623031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07623031 about?
NCT07623031 is a clinical study titled "Dual-Language B-MORE for Hypertension". This pilot study is a single-arm clinical feasibility trial evaluating the feasibility, acceptability, and preliminary efficacy of a brief adaptation of Mindfulness-Oriented Recovery Enhancement (B-MORE) for reducing stress and high blood pressure in hypertensive English- and Spanish-speaking patien...
What is the current status of trial NCT07623031?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07623031?
The interventions under investigation include: Behavioral: B-MORE (Brief Mindfulness-Oriented Recovery Enhancement) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07623031?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.